Search results
Found 34 matches for
Professor Irina Udalova appointed to the MRC’s Infections and Immunity Board
Department
1 March 2024
The Medical Research Council’s Infections and Immunity Board (IIB) funds research into infectious human disease and disorders of the human immune system.
Oxford-ZEISS Centre of Excellence officially opened
Department General Research
23 February 2024
ZEISS is partnering with the University of Oxford bringing ground-breaking microscopy imaging equipment, and analysis tools, to advance the study of global health and disease.
New PI will study the mechanical forces impacting cell fate decision-making and tissue dynamics in inflammatory diseases
Department General Research
23 November 2023
We welcome Adrien Hallou who has joined the Kennedy Institute as a new Principal Investigator. Adrien will be establishing his lab to better understand the role of mechanical forces on cell fate decisions and tissue dynamics in inflammatory diseases, with a particular focus on inflammatory skin diseases such as psoriasis or atopic dermatitis.
Kennedy Trust for Rheumatology Research visits the Kennedy Institute
Department
27 October 2023
The Kennedy Trust for Rheumatology Research (KTRR) visited the Kennedy Institute in early October. The Institute benefits extensively from the generous support of the KTRR and the visit was a great opportunity to share stories of our scientific successes and discuss future directions.
The Kennedy Institute celebrates support staff contributions
Department
5 September 2023
The lunch with sandwiches, tea and strawberries was attended by staff and students and provided an opportunity to give some well-earned Long Service Awards.
New approach to nail bed injury surgery could significantly cut NHS costs
Department
30 March 2023
According to a new Oxford study, changing clinical practice for finger injuries in children could save the NHS £720,000 per year.
The Kennedy Institute launches its single cell facility
Department
4 January 2023
We spoke to Irina Udalova and Stephen Sansom about the Kennedy’s new single cell facility and how it will enhance research at the Institute and beyond.
Professor Michael Dustin appointed new Chair in Molecular Immunology
Awards Department
6 December 2022
A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.
The Kennedy’s research strongly endorsed following independent review
Department
29 November 2022
We recently welcomed our Scientific Advisory Board (SAB) and the Kennedy Trust Scientific Review Board (TSRB) to the Institute to review our current activities and future plans.
Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease
Department
16 November 2022
Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.
Mathematician boosts data science research at the Kennedy Institute
Department
19 October 2022
Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.
NIHR funding for musculoskeletal and inflammatory disease research
Department Funding
17 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
Leducq Foundation grant boosts cardiovascular research
Department Funding
11 October 2022
The Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
Welcome to the new Kennedy Trust CEO
Department
12 July 2022
The Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.
Breakthrough in treatment for Dupuytren’s disease
Department
30 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
Professor Chris Buckley joins the Kennedy Institute as Director of Clinical Research
Department
12 January 2022
Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.
New Oxford-Zeiss Centre of Excellence opens at the University of Oxford
Department General
17 December 2021
The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.
The Kennedy Institute scoops sustainability award
Awards Department
2 December 2021
A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.
Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors
Department
23 November 2021
Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.
The Kennedy Institute Student Symposium returns for its 5th year
Department General
30 September 2021
A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.